Achieve Life Sciences Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Achieve Life Sciences, Inc. (ACHV) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-39.83-29.82-42.35-33.15-14.73-16.40-12.69
Depreciation & Amortization0.230.230.240.250.260.250.28
Stock Based Compensation5.333.443.272.191.290.000.00
Change in Working Capital2.41-0.780.080.04-0.700.580.93
Change in Accounts Receivable0.110.000.000.000.000.000.00
Change in Accounts Payable1.33-1.040.800.51-0.530.000.00
Change in Other Working Capital1.082.451.200.040.240.000.00
Other Operating Activities2.072.451.202.961.340.400.00
Net Cash from Operating Activities-29.77-24.48-37.57-29.44-13.47-15.22-10.62
Investing Activities
Capital Expenditures0.00-0.020.000.000.020.05-0.05
Acquisitions0.000.530.000.000.000.000.00
Purchases of Investments-21.580.000.000.000.000.000.00
Sales/Maturities of Investments26.310.000.000.000.005.09-5.09
Other Investing Activities0.000.000.000.000.000.000.01
Net Cash from Investing Activities-21.58-0.020.000.00-0.025.04-5.13
Financing Activities
Debt Repayment-18.110.000.000.000.000.000.00
Common Stock Issued56.9415.3019.2121.3432.730.0018.43
Common Stock Repurchased-0.11-0.03-0.050.000.000.000.00
Other Financing Activities0.75-0.22-0.050.00-0.050.000.00
Net Cash from Financing Activities48.5315.2819.3236.613.234.2019.76
Summary
Effect of Forex Changes on Cash0.000.000.000.000.000.000.00
Net Change in Cash-2.82-9.22-18.257.17-10.26-5.984.01
Cash at Beginning of Period15.6024.8243.0735.9016.719.575.56
Cash at End of Period12.7715.6024.8235.906.453.599.57
Free Cash Flow-29.77-24.50-37.57-29.44-13.49-15.27-10.67